ISA PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ISA PHARMA
Largest movements
- Cash +€25,402
up €25,402 (+21.0%), from €121,011 to €146,413
mainly Net result for the year (+€34,498) and Other debts (+€15,702)
- Stocks and contracts +€11,285
up €11,285 (+12.2%), from €92,260 to €103,545
- Tangible fixed assets -€8,670
down €8,670 (-11.0%), from €78,750 to €70,080
of which Land and buildings: -€9,398
- Receivables within one year +€7,178
up €7,178 (+58.7%), from €12,224 to €19,401
of which Trade receivables: +€8,533
- Other debts +€15,702
up €15,702 (+230.0%), from €6,827 to €22,530
- Reserves +€13,432
up €13,432 (+9.6%), from €140,455 to €153,887
of which Distributable reserves: +€13,432
- Debts after one year -€9,966
down €9,966 (-14.4%), from €69,416 to €59,450
- Tax, wage and social debts +€8,340
up €8,340 (+36.1%), from €23,119 to €31,459
of which Taxes: +€7,131
- Trade debts +€7,233
up €7,233 (+23.2%), from €31,139 to €38,373
- Gross operating margin +€12,327
up €12,327 (+6.2%), from €197,473 to €209,801
- Taxes +€4,078
up €4,078 (+42.3%), from €9,645 to €13,723
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €311,118 | €346,253 | +€35,135 | +11.3% |
| Formation expenses | 20 | €0 | €0 | = | |
| Fixed assets | 21/28 | €85,528 | €76,858 | -€8,670 | -10.1% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €78,750 | €70,080 | -€8,670 | -11.0% |
| Land and buildings | 22 | €76,771 | €67,373 | -€9,398 | -12.2% |
| Plant, machinery and equipment | 23 | €351 | €1,720 | +€1,369 | +390.1% |
| Furniture and vehicles | 24 | €1,628 | €987 | -€641 | -39.4% |
| Financial fixed assets | 28 | €6,779 | €6,779 | = | 0.0% |
| Current assets | 29/58 | €225,589 | €269,395 | +€43,805 | +19.4% |
| Stocks and contracts in progress | 3 | €92,260 | €103,545 | +€11,285 | +12.2% |
| Stocks | 30/36 | €92,260 | €103,545 | +€11,285 | +12.2% |
| Amounts receivable within one year | 40/41 | €12,224 | €19,401 | +€7,178 | +58.7% |
| Trade receivables | 40 | €10,869 | €19,401 | +€8,533 | +78.5% |
| Other amounts receivable | 41 | €1,355 | €0 | -€1,355 | -100.0% |
| Cash at bank and in hand | 54/58 | €121,011 | €146,413 | +€25,402 | +21.0% |
| Deferred charges and accrued income | 490/1 | €95 | €35 | -€60 | -63.2% |
| Total equity and liabilities | 10/49 | €311,118 | €346,253 | +€35,135 | +11.3% |
| Equity | 10/15 | €168,044 | €181,475 | +€13,432 | +8.0% |
| Contributions | 10/11 | €14,260 | €14,260 | = | 0.0% |
| Reserves | 13 | €140,455 | €153,887 | +€13,432 | +9.6% |
| Non-distributable reserves | 130/1 | €0 | €0 | = | |
| Reserves not available under the articles | 1311 | €0 | €0 | = | |
| Tax-exempt reserves | 132 | €0 | €0 | = | |
| Distributable reserves | 133 | €140,455 | €153,887 | +€13,432 | +9.6% |
| Profit (loss) carried forward | 14 | €13,329 | €13,329 | = | 0.0% |
| Provisions and deferred taxes | 16 | €0 | €0 | = | |
| Provisions for liabilities and charges | 160/5 | €0 | €0 | = | |
| Major repairs and maintenance | 162 | €0 | €0 | = | |
| Other liabilities and charges | 164/5 | €0 | €0 | = | |
| Amounts payable | 17/49 | €143,074 | €164,778 | +€21,704 | +15.2% |
| Amounts payable after more than one year | 17 | €69,416 | €59,450 | -€9,966 | -14.4% |
| Financial debts | 170/4 | €69,416 | €59,450 | -€9,966 | -14.4% |
| Amounts payable within one year | 42/48 | €73,658 | €105,327 | +€31,669 | +43.0% |
| Current portion of amounts payable after more than one year | 42 | €12,572 | €12,966 | +€394 | +3.1% |
| Trade debts | 44 | €31,139 | €38,373 | +€7,233 | +23.2% |
| Suppliers | 440/4 | €31,139 | €38,373 | +€7,233 | +23.2% |
| Taxes, remuneration and social security | 45 | €23,119 | €31,459 | +€8,340 | +36.1% |
| Taxes | 450/3 | €2,143 | €9,274 | +€7,131 | +332.8% |
| Remuneration and social security | 454/9 | €20,977 | €22,186 | +€1,209 | +5.8% |
| Other amounts payable | 47/48 | €6,827 | €22,530 | +€15,702 | +230.0% |
| Accrued charges and deferred income | 492/3 | €0 | €0 | = | |
| Remuneration, social security and pensions | 62 | €147,993 | €146,138 | -€1,855 | -1.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,088 | €10,221 | +€134 | +1.3% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €0 | €0 | = | |
| Other operating charges | 640/8 | €1,995 | €2,036 | +€41 | +2.1% |
| Non-recurring operating charges | 66A | €0 | €0 | = | |
| Gross operating margin | 9900 | €197,473 | €209,801 | +€12,327 | +6.2% |
| Operating profit (loss) | 9901 | €37,398 | €51,405 | +€14,007 | +37.5% |
| Financial income | 75/76B | €1,505 | €1,008 | -€497 | -33.0% |
| Recurring financial income | 75 | €1,505 | €1,008 | -€497 | -33.0% |
| Financial charges | 65/66B | €4,429 | €4,191 | -€238 | -5.4% |
| Recurring financial charges | 65 | €4,429 | €4,191 | -€238 | -5.4% |
| Profit (loss) for the period before taxes | 9903 | €34,474 | €48,222 | +€13,748 | +39.9% |
| Income taxes | 67/77 | €9,645 | €13,723 | +€4,078 | +42.3% |
| Profit (loss) for the period | 9904 | €24,829 | €34,498 | +€9,670 | +38.9% |
| Transfer from tax-exempt reserves | 789 | €0 | €0 | = | |
| Profit (loss) for the period to be appropriated | 9905 | €24,829 | €34,498 | +€9,670 | +38.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.